385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
forme pharmaceutique pour usage transdermique et/ou cutané	Is a	Type of drug preparation	false	Inferred relationship	Some
forme pharmaceutique pour usage transdermique et/ou cutané	Is a	forme pharmaceutique selon la voie d'administration	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Unguentum Cocois Co	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrous wool fat+zinc oxide 4/8% cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Soap substitute+zinc oxide 5% cream wash	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Urea 100 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely lauromacrogol 30 milligram/1 gram and urea 50 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Cetyl dimethicone 5% bath oil	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Soya oil+mixed lauromacrogols 82.95/15% bath oil	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Soya oil 84.75% bath oil	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Talc dusting powder BP	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Zinc+starch+talc dusting powder BPC	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Calamine compound application BP	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Calamine 4% aqueous cream BP	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Calamine lotion BP	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Calamine oily lotion	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Calamine 15% ointment BP	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Crotamiton 100 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely lidocaine 20 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Benzocaine 30 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely diphenhydramine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Doxepin hydrochloride 50 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone creams	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone 1 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone ointments	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone acetate 10 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Alclometasone dipropionate 500 microgram/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone valerate 0.12% foam	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone 0.1% scalp application	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone 0.1% cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone 0.1% ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone 0.1% lotion	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone+salicylic acid 0.05/3% scalp application	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Clobetasone butyrate 500 microgram/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Clobetasone butyrate 500 microgram/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Desoxymethasone 0.05% oily cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Diflucortolone valerate 0.1% oily cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Diflucortolone valerate 0.3% oily cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Diflucortolone valerate 3 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Fluocinolone acetonide 250 microgram/g cutaneous gel	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 25 microgram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Fluocinolone acetonide 250 microgram/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Fluocortolone 0.5% cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Fluocortolone 0.5% ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous emulsion (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone butyrate 1 mg/g cutaneous cream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone butyrate 0.1% lipocream	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Hydrocortisone butyrate 0.1% scalp lotion	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous cream (clinical drug)	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some
Mometasone furoate 1 mg/g cutaneous ointment	Has manufactured dose form	False	forme pharmaceutique pour usage transdermique et/ou cutané	Inferred relationship	Some

Start Previous Page 3 of 13 Next End

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
161731000077114	forme pharmaceutique pour usage transdermique et/ou cutané	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module